Publikationen 2010 - 2016

2016 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2016): Association of the Derived Neutrophil-Lymphocyte Ratio With Critical Limb Ischemia. Angiology. 2016; 67(4):350-354
(2016): mFast-SeqS as a Monitoring and Pre-screening Tool for Tumor-Specific Aneuploidy in Plasma DNA. Adv Exp Med Biol. 2016; 924: 147-155.
(2016): A synonymous EGFR polymorphism predicting responsiveness to anti-EGFR therapy in metastatic colorectal cancer patients. Tumour Biol. 2016; 37(6):7295-7303
(2016): Hope and social support in elderly patients with cancer and their partners: an actor-partner interdependence model. Future Oncol. 2016; 12(24):2801-2809
(2016): The width of resection margins influences local recurrence in soft tissue sarcoma patients. Eur J Surg Oncol. 2016; 42(6):899-906
(2016): Critical evaluation of KCNJ3 gene product detection in human breast cancer: mRNA in situ hybridisation is superior to immunohistochemistry. J Clin Pathol. 2016; 69(12):1116-1121
(2016): The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients. Tumour Biol. 2016; 37(1):361-368
(2016): Recent therapy options of gastrointestinal neuroendocrine tumours AUST J CLIN ENDOCR M. 2016; 9(1): 7-10.
(2016): Cancer patients' emotional distress, coping styles and perception of doctor-patient interaction in European cancer settings. Palliat Support Care. 2016; 14(3):204-211
(2016): Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells INT J MOL SCI. 2016; 17(12): 2011
(2016): Non-coding RNAs Enabling Prognostic Stratification and Prediction of Therapeutic Response in Colorectal Cancer Patients. Adv Exp Med Biol. 2016; 937: 183-204.
(2016): Recommendations of the Austrian Working Group on Pulmonary Pathology and Oncology for predictive molecular and immunohistochemical testing in non-small cell lung cancer MEMO-MAG EUR MED ONC. 2016; 9(4): 191-200.
(2016): NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients. Br J Cancer. 2016; 115(10):1264-1272
(2016): Overexpression of KCNJ3 gene splice variants affects vital parameters of the malignant breast cancer cell line MCF-7 in an opposing manner. BMC Cancer. 2016; 16:628-628
(2016): The AST/ALT (De-Ritis) ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. Medicine (Baltimore). 2016; 95(24): e3843-e3843.
(2016): Anomaly of the inferior vena cava and lactose malabsorption PHLEBOLOGIE. 2016; 45(1): 36-39.
(2016): Blood-Based Biomarkers Are Associated with Disease Recurrence and Survival in Gastrointestinal Stroma Tumor Patients after Surgical Resection. PLoS One. 2016; 11(7):e0159448-e0159448
(2016): The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma. J Clin Pathol. 2016; 69(4):326-330
(2016): Vitamin D and prostate cancer prognosis: a Mendelian randomization study. World J Urol. 2016; 34(4):607-611
(2016): Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer. Nat Commun. 2016; 7(9):12008-12008
(2016): Potentials, challenges and limitations of a molecular characterization of circulating tumor DNA for the management of cancer patients LABORATORIUMSMEDIZIN. 2016; 40(5): 323-334.
(2016): Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients INT J MOL SCI. 2016; 17(12): 2053
(2016): Serum sclerostin levels in renal cell carcinoma patients with bone metastases. Sci Rep. 2016; 6: 33551-33551.
Übersichtsarbeiten
(2016): Current Status of Long Non-Coding RNAs in Human Breast Cancer. Int J Mol Sci. 2016; 17(9):
(2016): MicroRNAs in Testicular Cancer Diagnosis and Prognosis. Urol Clin North Am. 2016; 43(1): 127-134.
(2016): Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers BIOMED RES INT. 2016; 2016: 4805270-4805270.
(2016): Current Insights into Long Non-Coding RNAs in Renal Cell Carcinoma. Int J Mol Sci. 2016; 17(4):573-573
(2016): Liquid biopsies. A multidisciplinary challenge for human geneticists, oncologists, and pathologists MED GENET-BERLIN. 2016; 28(2): 245-250.
(2016): Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs INT J MOL SCI. 2016; 17(12): 2080

2016 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2016): Analysis of ctDNA using the mFastSeqS and plasma-Seq methods for screening and therapy monitoring in prostate cancer patients CLIN CANCER RES. 2016; 22: -Meeting of the American-Association-for-Cancer-Research (AACR) Precision Medicine Series - Integrating Clinical Genomics and Cancer Therapy; JUN 13-16, 2015; Salt Lake, UT.
(2016): The CHA2DS2-VASc score strongly correlates with glomerular filtration rate and predicts decline in renal function over time in patients with atrial fibrillation and chronic kidney disease EUR HEART J. 2016; 37: 604-604.-Congress of the European-Society-of-Cardiology (ESC); AUG 27-31, 2016; Rome, ITALY.
(2016): Mediterrean Bridges and Drifts: The European Migrant Crisis and the Role of Psycho-oncology PSYCHO-ONCOLOGY. 2016; 25(SP. S3):90-91.Dublin,Ireland.
(2016): Are eIFs Ingredients for Neuroendocrine Tumorigenesis? NEUROENDOCRINOLOGY. 2016; 103: 2-3.-13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 09-11, 2016; Barcelona, SPAIN.
(2016): The impact of adjuvant denosumab on disease-free survival: Results from 3,425 postmenopausal patients of the ABCSG-18 trial CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
(2016): Impact of Early Surgery on Prognosis in Advanced Gastro-Entero-Pancreatic Neuroendocrine Tumours (GEP-NET) NEUROENDOCRINOLOGY. 2016; 103: 98-98.-13th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 09-11, 2016; Barcelona, SPAIN.
(2016): EGFR T790M resistance mutation in NSCLC: Real-life data of Austrian patients treated with osimertinib WIEN KLIN WOCHENSCHR. 2016; 128(19-20):769-770.
(2016): When is it time to discontinue cancer treatment? ONCOL RES TREAT. 2016; 39: 2-2.
(2016): Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up. J CLIN ONCOL. 2016; 34(4):-Gastrointestinal Cancers Symposium; JAN 21-23, 2016; San Francisco, CA.
(2016): Patterns of venous thromboembolism risk in patients with localized colorectal cancer undergoing adjuvant chemotherapy or active surveillance ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
(2016): Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Stage 1 results of a phase II trial (AGMT MBC-6) CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
(2016): Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: Updated safety results of a phase II trial (AGMT MBC-6) ANN ONCOL. 2016; 27: -41st Congress of the European-Society-for-Medical-Oncology (ESMO); OCT 07-11, 2016; Copenhagen, DENMARK.
(2016): Secondary resectability rates observed in a multicenter randomized phase II study of modified capecitabine/ irinotecan (mXELIRI) plus bevacizumab (bev) followed by capecitabine/oxaliplatin (XELOX) plus bev or the reverse sequence in patients with metastatic colorectal cancer (mCRC) ANN ONCOL. 2016; 27:
(2016): The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude WIEN KLIN WOCHENSCHR. 2016; 128: S309-S310.
(2016): Comprehensive molecular and immunological analysis to assess the tumor immune contexture in stage II and III colorectal cancer ANN ONCOL. 2016; 27:
(2016): Stromel co-expression of urokinase-type plasminogen activator (uPA) and plasminogen activator Inhibitor (PAI-1) protein by IHC predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer CANCER RES. 2016; 76: -38th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 08-12, 2015; San Antonio, TX.
(2016): Is it safe to use NSAIDs for pain control during chemical pleurodesis for malignant pleural effusion? WIEN KLIN WOCHENSCHR. .. 2016; 128(19-20):772-773.
(2016): An elevated fibrinogen/CRP ratio predicts a remarkable survival advantage in patients with metastatic pancreatic cancer ANN ONCOL. 2016; 27:
(2016): IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN AND NEUTROPHIL COUNTS IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULART HEALTH STUDY ATHEROSCLEROSIS. 2016; 252: E67-E67.-Congress of the European-Atherosclerosis-Society (EAS); MAY 29-JUN 01, 2016; Innsbruck, AUSTRIA.
(2016): Colonization with multidrug-resistant Gram-negative bacteria in long time care facilities: prevalence and risk factors WIEN KLIN WOCHENSCHR. 2016; 128: S387-S388.
(2016): Benefit and Risk Assessment for the Initiation of oral Anticoagulation in non-valvular Atrial Fibrillation: The Self-assessment by the Patient differs from the individual Risk Assessment by means of CHA2DS2-VASc and HASBLED Scores WIEN KLIN WOCHENSCHR. 2016; 128: S391-S392.
(2016): Benefit and Risk Assessment in Initiation of oral Anticoagulant in non valvularem Atrial Fibrillation: A Comparison between Self Assessment by the Patient and an individual Risk Assessment by CHA2DS2VASc and HAS-BLED Scores WIEN KLIN WOCHENSCHR. 2016; 128: S299-S300.

2015 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2015): A Case of Focal Small-cell Neuroendocrine Carcinoma in the Vicinity of the Extrahepatic Bile Duct, Adjacent to an Extensive Biliary Intraepithelial Neoplasm: A Diagnostic Challenge with Major Clinical Implications. Anticancer Res. 2015; 35(9):4821-4828
(2015): Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach. Clin Chem. 2015; 61(6): 838-849.
(2015): The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma. J Urol. 2015; 194(1): 30-35.
(2015): Preoperative serum-gamma-glutamyltransferase (GGT) does not represent an independent prognostic factor in a European cohort of patients with non-metastatic renal cell carcinoma. J Clin Pathol. 2015; 68(7): 547-551.
(2015): The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial BRIT J CANCER. 2015; 112(8): 1405-1410.
(2015): Elevated Blood Urea Nitrogen is Associated With Critical Limb Ischemia in Peripheral Arterial Disease Patients. Medicine (Baltimore). 2015; 94(24): e948-e948.
(2015): Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12. Ann Oncol. 2015; 26(2): 313-320.
(2015): Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype. ANN ONCOL. 2015; 26(8): 1685-1691.
(2015): Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study. Psychother Psychosom. 2015; 84(6):339-347
(2015): Preoperative Leucocytosis, Thrombocytosis and Anemia as Potential Prognostic Factors in Non-metastatic Renal Cell Carcinoma. Anticancer Res. 2015; 35(6): 3463-3469.
(2015): Pretreatment lymphocyte-monocyte ratio as a potential prognostic factor in a cohort of patients with upper tract urothelial carcinoma. J Clin Pathol. 2015; 68(5): 351-355.
(2015): An elevated preoperative plasma fibrinogen level is associated with poor disease-specific and overall survival in breast cancer patients. Breast. 2015; 24(5): 667-672.
(2015): Evaluation of the platelet-to-lymphocyte ratio as a prognostic indicator in a European cohort of patients with prostate cancer treated with radiotherapy. Urol Oncol. 2015; 33(5): 201.e9-201201.
(2015): Validation of the neutrophil-to-lymphocyte ratio as a prognostic factor in a cohort of European prostate cancer patients. World J Urol. 2015; 33(11): 1661-1667.
(2015): Association of vascular endothelial growth factor - A gene polymorphisms and haplotypes with breast cancer metastases. Acta Oncol. 2015; 54(3): 368-376.
(2015): Piezo1 forms mechanosensitive ion channels in the human MCF-7 breast cancer cell line. Sci Rep. 2015; 5:8364-8364
(2015): The role of polycomb repressive complexes in biliary tract cancer. Expert Opin Ther Targets. 2015; 19(3): 363-375.
(2015): The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells. Oncotarget. 2015; 7(1):745-758
(2015): 3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer. Anticancer Res. 2015; 35(9): 4697-4705.
(2015): MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015; 113(4): 569-573.
(2015): Combination of tumour markers CEA and CA19-9 improves the prognostic prediction in patients with pancreatic cancer. J Clin Pathol. 2015; 68(6):427-433
(2015): microRNAs and Colorectal Cancer. Adv Exp Med Biol. 2015; 889: 89-103.
(2015): MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients. Mol Carcinog. 2015; 54(11): 1442-1450.
(2015): Multi-omics in prognosis of hepatocellular carcinoma. Ann Transl Med. 2015; 3(1): 2-2.
(2015): Genetic variants within obesity-related genes are associated with tumor recurrence in patients with stages II/III colon cancer. Pharmacogenet Genomics. 2015; 25(1): 30-37.
(2015): The lymphocyte to monocyte ratio in peripheral blood represents a novel prognostic marker in patients with pancreatic cancer. Clin Chem Lab Med. 2015; 53(3):499-506
(2015): Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy. BMC Cancer. 2015; 15:1027-1027
(2015): The derived neutrophil/lymphocyte ratio predicts poor clinical outcome in soft tissue sarcoma patients. Am J Surg. 2015; 210(1): 111-116.
(2015): Uric acid levels in blood are associated with clinical outcome in soft-tissue sarcoma patients. Clin Chem Lab Med. 2015; 53(3): 493-497.
(2015): LGR5 rs17109924 is a predictive genetic biomarker for time to recurrence in patients with colon cancer treated with 5-fluorouracil-based adjuvant chemotherapy. Pharmacogenomics J. 2015; 15(5): 391-396.
(2015): The elevated C-reactive protein level is associated with poor prognosis in prostate cancer patients treated with radiotherapy. Eur J Cancer. 2015; 51(5): 610-619.
(2015): The association of an elevated plasma fibrinogen level with cancer-specific and overall survival in prostate cancer patients. World J Urol. 2015; 33(10): 1467-1473.
(2015): miR-199a and miR-497 Are Associated with Better Overall Survival due to Increased Chemosensitivity in Diffuse Large B-Cell Lymphoma Patients. Int J Mol Sci. 2015; 16(8):18077-18095
(2015): The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients. Eur J Haematol. 2015; 95(6):538-544
Kurzbericht/Letter
(2015): A glyco-engineered anti-HER2 monoclonal antibody (TrasGEX) induces a long-lasting remission in a patient with HER2 overexpressing metastatic colorectal cancer after failure of all available treatment options. J Clin Pathol. 2015; 68(12): 1044-1046.
Übersichtsarbeiten
(2015): The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer. J Gastrointestin Liver Dis. 2015; 24(2): 225-234.
(2015): Genetic markers of recurrence in colorectal cancer PHARMACOGENOMICS. 2015; 16(11): 1313-1326.
(2015): Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future. Anticancer Res. 2015; 35(11):5737-5744
(2015): MicroRNAs: Clinical Relevance in Colorectal Cancer. Int J Mol Sci. 2015; 16(12):28063-28076
Editorials
(2015): Circulating Tumor Cells: Where From Here? Semin Oncol. 2015; 42(4):515-517
Korrekturen

2015 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2015): What is the role of resection of primary tumor in metastatic breast cancer? What is the role of cancer stem cells and circulating tumor cells and clinical state of the art ONCOL RES TREAT. 2015; 38: 179-179.-Jahrestagung der DGHO, OeGHO, SGMO und SGH; 09.-13.10.2015; Basel.
(2015): Genetic variants of kinases suppressors of Ras (KSR) to predict tumor response to first-line cetuximab in patients with mCRC: Prospective analysis in the FIRE 3 trial J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
(2015): Pregancy-associated thrombotic thrombocytopenic purpura in a 26-year old primipara MED KLIN-INTENSIVMED. 2015; 110(4):302-302.-47. Jahrestagung der DGIIN/ÖGIAIN; JUN 17-19, 2015; Koeln, GERMANY.
(2015): The AST/ALT Ratio: A novel marker for critical limb ischemia in peripheral arterial occlusive disease Patients WIEN KLIN WOCHENSCHR. 2015; 127(17-18):721-721.
(2015): Adjuvant denosumab in breast cancer: Results from 3,425 postmenopausal patients of the ABCSG-18 trial. J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
(2015): &quotLoss of the tumor- and metastasis suppressor RAF kinase inhibitor protein is caused by the overexpression of miRNA-23a ONCOL RES TREAT. 2015; 38: 99-99.
(2015): Clinical utility of circulating tumor DNA in human cancers: A report of more than 300 plama-Seqs EUR J CANCER. 2015; 51: S33-S33.-European Cancer Congress; Sep 25-29, 2015; Vienna, AUSTRIA.
(2015): Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy versus targeted agents): A European single-center experience over 26 years. J CLIN ONCOL. 2015; 33(7):-Genitourinary Cancers Symposium; FEB 26-28, 2015; Orlando, FL.
(2015): Survival comparison analysis of two historical cohorts of metastatic renal cell carcinoma patients (cytokine therapy vs. targeted agents): A European single-center experience over 26 years J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
(2015): Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study EUR J CANCER. . 2015; 51: S716-S716.-European Cancer Congress; 2015; Vienna, AUSTRIA.
(2015): An elevated preoperative plasma fibrinogen level is related with poor prognosis in breast cancer. BREAST. 2015; 24: S104-S104.-14th St.Gallen International Breast Cancer Conference; MAR 18-21, 2015; Vienna, AUSTRIA.
(2015): Fifty-Three Year-Old-Male with a Symptomatic Ileocecal Carcinoid: An Individual Follow-Up of 14 Yrs with 5 Different Anti-Proliferative Therapies NEUROENDOCRINOLOGY. 2015; 102(1-2):151-151.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN.
(2015): An exploratory intervention study suggests clinical benefits of training in chronic stroke to be paralleled by changes in brain activity using repeated fMRI EUR J NEUROL. 2015; 22: 407-407.-1st Congress of the European-Academy-of-Neurology; June 20-23, 2015; Berlin, Germany.
(2015): Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest ACTA PHYSIOL. 2015; 213: 148-148.
(2015): DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2 ACTA PHYSIOL. 2015; 213: 147-148.
(2015): Functional imaging tests vs. computed tomography scan: detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up CANCER RES. 2015; 75: -106th Annual Meeting of the American-Association-for-Cancer-Research (AACR); APR 18-22, 2015; Philadelphia, PA.
(2015): Activity of regorafenib (RE) in leiomyosarcomas (LMS) and other types of soft-tissue sarcomas (OTS): Results of a doubleblind, randomized placebo (PL) controlled phase II trial J CLIN ONCOL. 2015; 33(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 29-JUN 02, 2015; Chicago, IL.
(2015): Hypoglycaemia in a Patient with Glucagonoma-Coincidence of a Glucagonoma and Insulinoma in a Patient with Multiple Endocrine Neoplasia Type I NEUROENDOCRINOLOGY. . 2015; 102(1-2):153-153.-12th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocrine Tumor Disease; MAR 11-13, 2015; Barcelona, SPAIN.
(2015): Low spinophilin expression is associated with poor prognosis and cellular growth in human breast cancer ANN ONCOL. IMPAKT Breast Cancer Conference. 2015; 26: -IMPAKT Breast Cancer Conference; MAY 07-09, 2015; Brussels, BELGIUM.
(2015): Metformin-assoziierte Laktat- und Ketoazidose in zwei kritisch kranken Patientinnen. Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA.
(2015): Influence of immunohistological detection of intratumoral urokinase-type plasminogen activator (uPA) on disease outcome in endocrine-treated postmenopausal patients with hormone receptor-positive early breast cancer. J CLIN ONCOL. 2015; 33(15):
(2015): Bevacizumab in combination with docetaxel plus trastuzumab +/- non-pegylated liposomal doxorubicin: Final results of ABCSG-32, a prospective, randomized phase II-study CANCER RES. 2015; 75(9):-37th Annual CTRC-AACR San Antonio Breast Cancer Symposium; DEC 09-13, 2014; San Antonio, TX.
(2015): MiR-199a and miR-497 are associated with better overall survival due to increased chemosensitivity in aggressive non-Hodgkin's lymphoma patients ONCOL RES TREAT. 2015; 38: 63-64.

2014 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2014): The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy. Pharmacogenomics J. 2014; 14(2):130-134
(2014): Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer. Hum Pathol. 2014; 45(4):683-690
(2014): Tumor macroenvironment and metabolism. Semin Oncol. 2014; 41(2): 281-295.
(2014): Validation of pretreatment neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. BJU Int. 2014; 114(3):334-339
(2014): Validation of the pretreatment derived neutrophil-lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinoma. Br J Cancer. 2014; 110(10):2531-2536
(2014): NR4A1-mediated apoptosis suppresses lymphomagenesis and is associated with a favorable cancer-specific survival in patients with aggressive B-cell lymphomas. Blood. 2014; 123(15): 2367-2377.
(2014): Surgical therapy of primary malignant bone tumours and soft tissue sarcomas of the chest wall: a two-institutional experience. Int Orthop. 2014; 38(6):1235-1240
(2014): Serum Metal Ion Concentrations in Paediatric Patients following Total Knee Arthroplasty Using Megaprostheses. Biomed Res Int. 2014; 2014: 817257-817257.
(2014): Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. Int J Clin Pract. 2014; 68(12):1483-1487
(2014): Physician awareness of knee and hip pain in the context of coronary heart disease treatment. ScientificWorldJournal. 2014; 2014(4):494801-494801
(2014): Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. Ann Oncol. 2014; 25(2):339-345
(2014): Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1. Mod Pathol. 2014; 27(6):906-915
(2014): Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma. Urol Oncol. 2014; 32(7):1041-1048
(2014): The hypothalamic-pituitary-gonadal axis and prostate cancer: implications for androgen deprivation therapy. World J Urol. 2014; 32(3):669-676
(2014): Nephroblastomas Show Low Expression of MicroR-204 and High Expression of Its Target, the Oncogenic Transcription Factor MEIS1. Pediatr Dev Pathol. 2014; 17(3): 169-175.
(2014): The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients. Br J Cancer. 2014; 110(10):2524-2530
(2014): Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy. Strahlenther Onkol. 2014; 190(4):364-369
(2014): The influence of elevated levels of C-reactive protein and hypoalbuminemia on survival in patients with advanced inoperable esophageal cancer undergoing palliative treatment. J Surg Oncol. 2014; 110(6):645-650
(2014): Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. PLoS Genet. 2014; 10(3):e1004271-e1004271
(2014): Plastin polymorphisms predict gender- and stage-specific colon cancer recurrence after adjuvant chemotherapy. Mol Cancer Ther. 2014; 13(2):528-539
(2014): Association of common gene variants in the WNT/β-catenin pathway with colon cancer recurrence. Pharmacogenomics J. 2014; 14(2):142-150
(2014): Validation of the preoperative plasma fibrinogen level as a prognostic factor in a European cohort of patients with localized upper tract urothelial carcinoma. J Urol. 2014; 191(4):920-925
(2014): MiR-200a regulates epithelial to mesenchymal transition-related gene expression and determines prognosis in colorectal cancer patients. Br J Cancer. 2014; 110(6):1614-1621
(2014): miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor. J Clin Pathol. 2014; 67(3):198-203
(2014): The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO). Ann Oncol. 2014; 25(1): 9-15.
(2014): An internally and externally validated prognostic score for metastatic breast cancer: analysis of 2269 patients. Ann Oncol. 2014; 25(3):633-638
(2014): Spinophilin expression determines cellular growth, cancer stemness and 5-flourouracil resistance in colorectal cancer. Oncotarget. 2014; 5(18): 8492-8502.
(2014): Evaluation of the physical activity biography: sport and transport. J Sports Sci Med. 2014; 13(2):338-348
(2014): Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24) ANN ONCOL. 2014; 25(2): 366-371.
(2014): The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer. 2014; 110(2):435-440
(2014): Evaluation of uric acid as a prognostic blood-based marker in a large cohort of pancreatic cancer patients. PLoS One. 2014; 9(8):e104730-e104730
(2014): Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients. Pharmacogenet Genomics. 2014; 24(12): 588-596.
(2014): The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer. 2014; 135(2):362-370
(2014): Pre-treatment anemia is a poor prognostic factor in soft tissue sarcoma patients. PLoS One. 2014; 9(9):e107297-e107297
(2014): The elevated preoperative platelet to lymphocyte ratio predicts decreased time to recurrence in colon cancer patients. Am J Surg. 2014; 208(2):210-214
(2014): A functional germline variant in GLI1 implicates hedgehog signaling in clinical outcome of stage II and III colon carcinoma patients. Clin Cancer Res. 2014; 20(6):1687-1697
(2014): The elevated pre-operative plasma fibrinogen level is an independent negative prognostic factor for cancer-specific, disease-free and overall survival in soft-tissue sarcoma patients. J Surg Oncol. 2014; 109(2):139-144
(2014): Validation of C-reactive protein levels as a prognostic indicator for survival in a large cohort of pancreatic cancer patients. Br J Cancer. 2014; 110(1):183-188
(2014): Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy. Strahlenther Onkol. 2014; 190(3):304-309
(2014): The derived neutrophil to lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Br J Cancer. 2014; 110(2):369-374
(2014): C-reactive protein level is a prognostic indicator for survival and improves the predictive ability of the R-IPI score in diffuse large B-cell lymphoma patients. Br J Cancer. 2014; 111(1): 55-60.
(2014): MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines. Int J Mol Sci. 2014; 15(11):20134-20157
Kurzbericht/Letter
(2014): The BRAF V600K mutation is more frequent than the BRAF V600E mutation in melanoma in situ of lentigo maligna type. J Invest Dermatol. 2014; 134(2):548-550
Übersichtsarbeiten
(2014): Complete recovery of a wide local reaction by the use of dexrazoxane 72 hours after epirubicin extravasation: case report and review of the literature. Dermatology. 2014; 229(4):288-292
(2014): MicroRNAs in Testicular Cancer: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy. Anticancer Res. 2014; 34(6):2709-2713
(2014): Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer. Int J Mol Sci. 2014; 15(8):13993-14013
(2014): MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer. World J Gastroenterol. 2014; 20(33): 11727-11735.
(2014): MicroRNAs in Diffuse Large B-Cell Lymphoma: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy. Anticancer Res. 2014; 34(2): 557-564.

2014 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2014): The Reality of Caregivers of Patients with Cancer in Austria PSYCHO-ONCOLOGY. 2014; 23: 48-49.-16 World Wongress of Psychooncology and Psychosocial Academy; OCT 20-24; Lissabon, Portugal.
(2014): Tailoring local therapy in post-menopausal endocrine responsive HER2neu negative breast cancer patients based on their genetic risk profile using Endopredict. EUR J CANCER. 2014; 50: S97-S97.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
(2014): Elevated blood urea nitrogen is associated with CLI in PAOD patients EUR HEART J. 2014; 35: 631-631.-Congress of the European-Society-of-Cardiology (ESC); AUG 30-SEP 03, 2014; Barcelona, SPAIN.
(2014): An Unexpected Outcome: Psychological Distress among Israeli Cancer Patients and Their Spousal Caregivers PSYCHO-ONCOLOGY. .. 2014; 23: 45-45.-16th World Congress of Psychooncology and PSychosocial Academy; OCT 20-24; Lissabon, Portugal.
(2014): Changes in colorectal carcinoma genomes under anti-EGFR therapy identified by whole-genome plasma DNA sequencing. EUR J CANCER. 2014; 50: S96-S96.-EACR 2014; München.
(2014): High preoperative monocyte-lymphocyte ratio (MLR) as a prognostic factor in nonmetastatic clear cell renal cell carcinoma. J CLIN ONCOL. 2014; 32(4):
(2014): OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM.
(2014): Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck ONCOL RES TREAT. 2014; 37: 273-273.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie.; Oct 10-14, 2014; Hamburg, Deutschland.
(2014): The elevated preoperative platelet to lymphocyte ratio is an independent prognostic marker in breast cancer patients EUR J CANCER. 2014; 50: S213-S213.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
(2014): Elevated plasma fibrinogen levels as an independent prognostic marker in breast cancer patients. STRAHLENTHER ONKOL. 2014; 190: 26-26.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY.
(2014): The preoperative Platelet/Lymphocyte Ratio is a predictive Factor for the Prognosis of Female Breast Cancer Patients. STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA.
(2014): Effect of Pentoxifylline on the Expression of IL1 beta and NF-kappa B in the Oral Mucous Membrane (Mouse) during fractionated Irradiation. STRAHLENTHER ONKOL. 2014; 190(1):129-129.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA.
(2014): Mechano-Sensitive Ion Channels (MSCS) Provide Human Breast Cancer Cells with a Sensorium for Mechanical Stress. BIOPHYS J. 2014; 106(2):549A-550A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA.
(2014): G-Protein Activated Inwardly Rectifying Potassium Channels Control Motility of Breast Cancer Cells. BIOPHYS J. 2014; 106(2):543A-543A.-58th Annual Meeting of the Biophysical-Society; FEB 15-19, 2014; San Francisco, CA.
(2014): Germline variants in the semaphorin SEMA4A confer susceptibility to familial colorectal cancer type X Oncol Res Treat. 2014; 37(S5):105-105.-Annual Meeting of the German, Austrian and Swiss Associations of Hematology and Medical Oncology; OCT 10-14, 2014; Hamburg, GERMANY. (ISBN: 978-3-318-02811-9 )
(2014): Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD). AM J TRANSPLANT. 2014; 14: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
(2014): Oxidative Stress and Apoptosis in a Pig Model of Brain Death (BD) and Living Donation (LD). TRANSPLANTATION. 2014; 98: 372-372.-World Transplant Congress; JUL 26-31, 2014; San Francisco, CA.
(2014): N/L Ratio does not have predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy EUR J CANCER. 2014; 50: S193-S193.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
(2014): Higher levels of HNE are associated with disease aggressiveness and worse outcome in breast cancer patients EUR J CANCER. 2014; 50: S70-S70.-9th European Breast Cancer Conference (EBCC); MAR 19-21, 2014; Glasgow, SCOTLAND.
(2014): The elevated C-reactive protein (CRP) level is a poor prognostic factor in prostate cancer patients ONCOL RES TREAT. 2014; 37: 179-179.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie 2014.; OCT 10-14, 2014; Hamburg, GERMANY.
(2014): Relation between Polymorphisms in the Apoptotic Genes FAS and FASL and radiogenic Long-Terms-Effects in Prostate Cancer Patients. STRAHLENTHER ONKOL. 2014; 190(1):127-127.-30th OEGRO Annual Conference; SEP 20-21, 2013; Bregenz, AUSTRIA.
(2014): C-reactive Protein (CRP) as a prognostic Marker in non-metastatic Prostate Cancer Patients STRAHLENTHER ONKOL. 2014; 190: 61-61.-20th Annual Congress of the German-Society-for-Radiation-Oncology; JUL 03-06, 2014; Dusseldorf, GERMANY.
(2014): HIGH EXPRESSION OF MIRNA-199A_1 AND MIRNA-497_1 IS ASSOCIATED WITH BETTER OVERALL SURVIVAL IN AGGRESSIVE NON-HODGKIN'S LYMPHOMA HAEMATOLOGICA. 2014; 99: 135-135.

2013 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2013): A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013; 109(2):395-400
(2013): A common and functional gene variant in the vascular endothelial growth factor a predicts clinical outcome in early-stage breast cancer. Mol Carcinog. 2013; 52 Suppl 1(9):E96-102
(2013): Preoperative neutrophil-to-lymphocyte ratio predicts clinical outcome in patients with stage II and III colon cancer. Anticancer Res. 2013; 33(10):4591-4594
(2013): Clusterin expression in elastofibroma dorsi. Histol Histopathol. 2013; 28(5):597-603
(2013): Low expression of the putative tumour suppressor spinophilin is associated with higher proliferative activity and poor prognosis in patients with hepatocellular carcinoma. Br J Cancer. 2013; 108(9):1830-1837
(2013): Clinical and laboratory profiles of a large cohort of patients with different grades of varicocele. Cent European J Urol. 2013; 66(1):71-74
(2013): The ethics of space, design and color in an oncology ward. Palliat Support Care. 2013; 11(3):215-221
(2013): Comprehensive analysis of alterations in the miRNome in response to photodynamic treatment. J Photochem Photobiol B. 2013; 120(6):74-81
(2013): Genetic and epigenetic analysis of putative breast cancer stem cell models. BMC Cancer. 2013; 13(7):358-358
(2013): Circulating Tumor Cells: From Bench to Bedside. Annu Rev Med. 2013; 64(7):31-44
(2013): Duplex reverse-hybridization assay for the simultaneous detection of KRAS/BRAF mutations in FFPE-extracted genomic DNA from colorectal cancer specimens. Dis Markers. 2013; 34(3):171-177
(2013): Successful use of sorafenib after bortezomib failure in metastatic follicular thyroid cancer - a case report. Onkologie. 2013; 36(6):368-370
(2013): Neutrophil-to-lymphocyte ratio and its association with critical limb ischemia in PAOD patients. PLoS One. 2013; 8(2):e56745-e56745
(2013): Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One. 2013; 8(7):e67688-e67688
(2013): Heterogeneity of Epidermal Growth Factor Receptor Status and Mutations of KRAS/PIK3CA in Circulating Tumor Cells of Patients with Colorectal Cancer. Clin Chem. 2013; 59(1):252-260
(2013): Novel Biomarkers to Detect Infection in Revision Hip and Knee Arthroplasties. Clin Orthop Relat Res. 2013; 471(8):2621-2628
(2013): The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial. Br J Cancer. 2013; 109(3):589-596
(2013): The predictive value of serum soluble E-cadherin levels in breast cancer patients undergoing preoperative systemic chemotherapy. Clin Biochem. 2013; 46(15):1585-1589
(2013): Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma. Histopathology. 2013; 63(3):309-315
(2013): Quality control of RNA preservation and extraction from paraffin-embedded tissue: implications for RT-PCR and microarray analysis. PLoS One. 2013; 8(7):e70714-e70714
(2013): Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced squamous cell carcinoma of the head and neck. Eur J Cancer. 2013; 49(2):352-359
(2013): Apoptosis in cancer cells induced by photodynamic treatment - a methodological approach. J PORPHYR PHTHALOCYA. 2013; 17(3): 197-209.
(2013): Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial. Br J Cancer. 2013; 108(7):1408-1414
(2013): Comparison of the 2002 and 2010 TNM classification systems regarding outcome prediction in clear cell and papillary renal cell carcinoma. Histopathology. 2013; 62(2):237-246
(2013): Predictive ability of the 2002 and 2010 versions of the Tumour-Node-Metastasis classification system regarding metastasis-free, cancer-specific and overall survival in a European renal cell carcinoma single-centre series. BJU Int. 2013; 111(4 Pt B):E191-E195
(2013): Presence and extent of histological tumour necrosis is an adverse prognostic factor in papillary type 1 but not in papillary type 2 renal cell carcinoma. Histopathology. 2013; 62(2):219-228
(2013): Validation of the pre-treatment neutrophil-lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients. Br J Cancer. 2013; 108(4):901-907
(2013): High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patients. Br J Cancer. 2013; 109(5):1123-1129
(2013): Three Metachronous Osteosarcomas within 22 Years without Pulmonary Metastases: A Case Report and Review of the Literature. Case Rep Orthop. 2013; 2013:197287-197287
(2013): The Austrian experience with trabectedin in non-selected patients with metastatic soft tissue sarcoma (STS). J Cancer Res Clin Oncol. 2013; 139(8):1337-1342
(2013): Neuropathic cancer pain: prevalence, severity, analgesics and impact from the European Palliative Care Research Collaborative-Computerised Symptom Assessment study. Palliat Med. 2013; 27(8):714-721
(2013): The pluripotent renal stem cell regulator SIX2 is activated in renal neoplasms and influences cellular proliferation and migration. Hum Pathol. 2013; 44(3):336-345
(2013): Oxidative stress and apoptosis in a pig model of brain death (BD) and living donation (LD). J Transl Med. 2013; 11(10):244-244
(2013): Are the new breast cancer subtypes (luminal A, B etc.) of practical impact? Yes]. Dtsch Med Wochenschr. 2013; 138(41):2096-2096
(2013): Clinico-pathological characteristics and clinical outcome of different histological types of pancreatic cancer in a large Middle European series. J Clin Pathol. 2013; 66(9):753-757
(2013): Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013; 109(2):416-421
(2013): Common gene variants in RAD51, XRCC2 and XPD are not associated with clinical outcome in soft-tissue sarcoma patients. Cancer Epidemiol. 2013; 37(6):1003-1009
(2013): Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients. Br J Cancer. 2013; 108(8):1677-1683
(2013): Association of common gene variants in vitamin D modulating genes and colon cancer recurrence. J Cancer Res Clin Oncol. 2013; 139(9):1457-1464
(2013): Validation of the prognostic relevance of plasma C-reactive protein levels in soft-tissue sarcoma patients. Br J Cancer. 2013; 109(9):2316-2322
(2013): External validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients. PLoS One. 2013; 8(11):e78225-e78225
(2013): A common gene variant in PLS3 predicts colon cancer recurrence in women. Tumour Biol. 2013; 34(4):2183-2188
Kurzbericht/Letter
(2013): Safety and efficacy of neoadjuvant FOLFIRINOX treatment in a series of patients with borderline resectable pancreatic ductal adenocarcinoma. Acta Oncol. 2013; 52(6):1231-1233
Übersichtsarbeiten
(2013): The role of microRNAs in breast cancer stem cells. Int J Mol Sci. 2013; 14(7):14712-14723
(2013): Targeting signaling pathways in epithelial ovarian cancer. Int J Mol Sci. 2013; 14(5):9536-9555
(2013): Hedgehog signaling pathway in ovarian cancer. Int J Mol Sci. 2013; 14(1):1179-1196
Korrekturen
(2013): Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable as well as inoperable pancreatic cancer. Br J Cancer. 2013; 109(7): 2026-2026.
Kommentare
(2013): Reply: Comment on 'Elevated preoperative neutrophil/lymphocyte ratio is associated with poor prognosis in soft-tissue sarcoma patients' Br J Cancer. 2013; 108(12):2627-2627
(2013): Reply: comment on 'A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients'. Br J Cancer. 2013; 109(12):3126-3127

2013 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2013): Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck. MODERN PATHOL. . 2013; 26(S2):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
(2013): Reduced Expression of the Putative Tumour Suppressor Spinophilin Is an Adverse Prognostic Factor in Squamous Cell Carcinoma of the Head and Neck. LAB INVEST. . 2013; 93(S1):301A-301A.-102nd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP); MAR 02-08, 2013; Baltimore, MD.
(2013): Doctor-patient communication and socioeconomic aspects ONKOLOGIE. 2013; 36: 24-24.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie ; OCT 18-22, 2013; Vienna, Austria.
(2013): Hope and Meaning in the Context of Different Psychological Intervention Settings: When to Whom - How?. PSYCHO-ONCOL. 2013; 22: 175-175.-15th World Congress of Psychooncology Innovation in Psychooncology, clinical care- research- advocacy ; NOV 4-8, 2013; Rotterdam, Netherlands.
(2013): Hope and Optimism - The Additional Benefit for Patients With Cancer in the Interdisciplinary Treatment - From the Perspective of Psychoneuroimmunology. PSYCHO-ONCOL. 2013; 22: 175-176.-15th World Congress of Psychooncology, Innovation in Psychooncology, clinical care- research-advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
(2013): Is there an overall survival benefit with regard to additional treatment options in the sequential therapy of patients with metastatic renal cell cancer? ONKOLOGIE. 2013; 36: 202-202.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; Oct 18-22, 2013; Wien.
(2013): Pathomechanism of reobstruction after endovascular treatment of the superficial femoral artery: impact of inflammatory cells J THROMB HAEMOST. .. 2013; 11: 863-863.
(2013): Emesis and Quality of Life Among European Cancer Patients. PSYCHO-ONCOL. 2013; 22: 278-278.-15th World Congress of Psychooncology Innovation in Psychooncology, clinical care- research- advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
(2013): Effects of psycho-social variables on compliance and adherence in patients with cancer: A literature overview and preliminary data of a study relating antiemetic therapy during chemotherapy in a sample of patients treated at the Division of Oncology, Graz ONKOLOGIE. 2013; 36: 109-109.
(2013): Lymphocyte-to-monocyte ratio: a novel marker for critical limb ischemia in PAOD patients. WIEN KLIN WOCHENSCHR. 2013; 125(17-18):554-555.
(2013): A LARGE SCALE VALIDATION STUDY PROPOSES HIGH PRE-OPERATIVE PLASMA FIBRINOGEN LEVELS AS AN INDEPENDENT NEGATIVE PROGNOSTIC FACTOR REGARDING CANCER-SPECIFIC, METASTASIS-FREE, AS WELL AS OVERALL SURVIVAL IN A EUROPEAN COHORT OF RENAL CELL CARCINOMA PATIENTS J UROLOGY. 2013; 189(4): E300-E301.
(2013): The Relationship between VEGF Gene polymorphisms and Haplotypes with the Development of Distant metastases in postmenopausal Breast cancer patients STRAHLENTHER ONKOL. . 2013; 189(2):182-183.-29th Annual Meeting of the Austrian-Society-of-Radiation-Oncology-Radiobiology-and-Medical-Radiophysics (OGRO); SEP 28-29, 2012; Gnunden, AUSTRIA.
(2013): Association between VEGF-A gene variants and clinical outcome in prostate cancer patients treated with definitive radiotherapy EUR J CANCER. 2013; 49: S689-S689.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
(2013): Association Between Doctor-Patient Relationship and Maladaptive Coping to Cancer in European Countries. PSYCHO-ONCOL. 2013; 22: 133-134.-15th World Congress of Psychooncology Innovation in Psychooncology, clinical care- research- advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
(2013): Beliefs About Medicines Among Cancer Patients: An International Study. PSYCHO-ONCOL. 2013; 22: 355-355.-15th World Congress of Psychooncology Innovation in Psychooncology, clinical care- research- advocacy; NOV 4-8, 2013; Rotterdam, Netherlands.
(2013): Characterization of Different Gene Families Encoding for Pro-Apoptotic and Anti-Apoptotic as well as Genes Encoding for Oxidative Stress induced Cell Damage in Organ Transplantation: An Animal Study. American Journal of Transplantation; Supplement 5. 2013; 13(5):400-400.-American Transplant Congress; May 18 - 22, 2013; Seattle, USA.
(2013): OXIDATIVE STRESS AND APOPTOSIS IN A PIG MODEL OF BRAIN DEATH (BD) AND LIVING DONATION (LD) TRANSPL INT. . 2013; 26: 222-223.
(2013): Neutrophil/Lymphocyte Ratio does not have predictive or prognostic value in breast cancer patients undergoing neoadjuvant systemic therapy ONKOLOGIE. 2013; 36: 158-158.
(2013): Higher levels of HNE are associated with disease aggressiveness and worse outcome of breast cancer patients ONKOLOGIE. 2013; 36: 176-176.
(2013): Genetic variants in DNA repair genes and radiation-induced late toxicity in prostate cancer patients EUR J CANCER. 2013; 49: S693-S693.-17th ECCO / 38th ESMO / 32nd ESTRO European Cancer Congress on Reinforcing Multidisciplinarity; SEP 27-OCT 01, 2013; Amsterdam, NETHERLANDS.
(2013): COST OF CANCER IN THE AUSTRIAN HOSPITAL SETTING VALUE HEALTH. 2013; 16(7): A407-A407.

2012 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2012): NEMO expression in human hepatocellular carcinoma and its association with clinical outcome. Hum Pathol. 2012; 43(7):1012-1019
(2012): MicroRNAs in Renal Cell Carcinoma: Implications for Pathogenesis, Diagnosis, Prognosis and Therapy. Anticancer Res. 2012; 32(9):3727-3732
(2012): Progress in circulating tumor cell capture and analysis: implications for cancer management. Expert Rev Mol Diagn. 2012; 12(3):303-312
(2012): Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group. J CLIN ONCOL. 2012; 30(7): 722-728.
(2012): Asymptomatic deep vein thrombosis and superficial vein thrombosis in ambulatory cancer patients: impact on short-term survival. Br J Cancer. 2012; 107(8):1244-1248
(2012): Treatment of Bone Metastases in Patients with Advanced Breast Cancer. Breast Care (Basel). 2012; 7(2):92-98
(2012): IL-7, IL-18, MCP-1, MIP1-β, and OPG as biomarkers for pain treatment response in patients with cancer. Pain Physician. 2012; 15(6):499-510
(2012): Computer-based symptom assessment is feasible in patients with advanced cancer: results from an international multicenter study, the EPCRC-CSA. J Pain Symptom Manage. 2012; 44(5):639-654
(2012): Interviews with patients with advanced cancer--another step towards an international cancer pain classification system. Support Care Cancer. 2012; 20(10):2491-2500
(2012): Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors. Transl Res. 2012; 159(6):487-496
(2012): Human Intraoral Harvested Mesenchymal Stem Cells: Characterization, Multilineage Differentiation Analysis, and 3-Dimensional Migration of Natural Bone Mineral and Tricalcium Phosphate Scaffolds. J Oral Maxillofac Surg. 2012; 70(10):2309-2315
(2012): Prognostic value of the Leibovich prognosis score supplemented by vascular invasion for clear cell renal cell carcinoma. J Urol. 2012; 187(3):834-839
(2012): Trends of stage, grade, histology and tumour necrosis in renal cell carcinoma in a European centre surgical series from 1984 to 2010. J Clin Pathol. 2012; 65(8):721-724
(2012): Renal cell carcinoma stage migration in a single European centre over 25 years: effects on 5- and 10-year metastasis-free survival. Int Urol Nephrol. 2012; 44(4):997-1004
(2012): Histologic tumor necrosis is an independent prognostic indicator for clear cell and papillary renal cell carcinoma. Am J Clin Pathol. 2012; 137(2): 283-289.
(2012): Cardiac fibrosis in human transplanted hearts is mainly driven by cells of intracardiac origin. J Am Coll Cardiol. 2012; 59(11): 1008-1016.
(2012): Down-regulation of KRAS-interacting miRNA-143 predicts poor prognosis but not response to EGFR-targeted agents in colorectal cancer. Br J Cancer. 2012; 106(11):1826-1832
(2012): Sunitinib causes dose-dependent negative functional effects on myocardium and cardiomyocytes. BJU Int. 2012; 110(10):1455-1462
(2012): Mobile geriatric consultant services for rest homes. Study of the effects of consultations by internal medicine specialists in the medical care of rest home residents]. Z Gerontol Geriatr. 2012; 45(8):735-741
(2012): Histiocytic sarcoma - targeted therapy: novel therapeutic options? A series of 4 cases. Onkologie. 2012; 35(7-8):447-450
(2012): Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer. Mol Genet Genomics. 2012; 287(9):755-764
(2012): The Functional Polymorphism of Erythropoietin Gene rs1617640 G>T Is Not Associated with Susceptibility and Clinical Outcome of Early-stage Breast Cancer. Anticancer Res. 2012; 32(8):3473-3478
(2012): Influence of five potential anticancer drugs on wnt pathway and cell survival in human biliary tract cancer cells. Int J Biol Sci. 2012; 8(1):15-29
Kurzbericht/Letter
(2012): Genetic prediction of radiation-induced morbidity in prostate cancer patients. Radiother Oncol. 2012; 105(3): 380-381.
Übersichtsarbeiten
(2012): Current status of therapeutic targeting of developmental signalling pathways in oncology. Curr Pharm Biotechnol. 2012; 13(11):2184-2220
(2012): Size-based enrichment technologies for CTC detection and characterization. Recent Results Cancer Res. 2012; 195: 87-95.

2012 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2012): The preoperative neutrophil to lymphocyte ratio predicts disease-free survival and overall survival in patients with stage II and III colon cancer. ONKOLOGIE. ONKOLOGIE35: 55-56. BASEL: KARGER;
(2012): Prognostic relevance of Mallory-Denk and intracytoplasmic hyaline bodies in hepatocellular carcinoma HEPATOLOGY. 2012; 56: 474A-475A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
(2012): PROGNOSTIC RELEVANCE OF MALLORY-DENK BODIES AND INTRACELLULAR HYALINE BODIES IN HEPATOCELLULAR CARCINOMA J HEPATOL. 2012; 56: S287-S287.
(2012): Reduction of NR4A1 is associated with poor survival aggressive lymphomas. ONKOLOGIE. 2012; 35: 104-104.-Gemeinsame Jahrestagung 2012 der DGHO, ÖGHO, SGMO und SGH+SSH ; Okt 19-23, 2012; Stuttgart.
(2012): NR4A1 Mediated Apoptosis of Aggressive Lymphoma Cells Suppresses Tumor Growth in a Xenograft Model. BLOOD. . 2012; 120(21):-54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH); DEC 08-11, 2012; Atlanta, GA.
(2012): Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival WIEN KLIN WOCHENSCHR. 2012; 124(15-16):559-559.-43. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22, 2012; ; ; Graz, AUSTRIA. . .
(2012): Asymptomatic venous thrombotic events in ambulatory cancer patients: impact on survival THROMB RES. 2012; 129: S181-S181.-6th International Conference on Thrombosis and Hemostasis Issues in Cancer; APR 20-22, 2012; Bergamo, ITALY.
(2012): IDENTIFICATION OF PROGNOSTIC METHYLATION MARKERS IN PATIENTS WITH EARLY STAGE COLORECTAL CANCER. ANN ONCOL. 2012; 23: 87-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
(2012): COMMON VEGF GENE POLYMORPHISMS ARE NOT ASSOCIATED WITH RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS. ANN ONCOL. 2012; 23: 86-87.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
(2012): Genetic variants of UGT1A4 and their impact on relapse-free survival in Tamoxifen treated breast cancer patients. Onkologie. 2012; 35(S 6):64-64.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 19-23, 2012; Stuttgart, GERMANY.
(2012): The Role of VEGF Gene Polymorphisms in the Development of Distant Metastases in Postmenopausal Breast Cancer Patients EUR J CANCER. .... 2012; 48(1):S184-S185.-8th European Breast Cancer Conference (EBCC); MAR 21-24, 2012; Vienna, AUSTRIA.
(2012): Association Between Variants in the VEGF Gene and Distant Metastases in Postmenopausal Breast Cancer Patients. EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012)
(2012): The Development of Distant Metastases in Postmenopausal Woman with Breast Cancer in Association with VEGF Gene Polymorphisms EUR J CANCER. 2012; 48: 63-63.-24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 06-09, 2012; Dublin, IRELAND.
(2012): COMPARISON OF OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER PATIENTS - DAILY PRACTICE VERSUS RANDOMIZED TRIALS. ANN ONCOL. 2012; 23: 95-95.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
(2012): Analysis of functional germline polymorphisms for prediction of response to anthracycline-based neoadjuvant chemotherapy in breast cancer WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
(2012): The functional polymorphism of erythropoietin gene rs1617640 G > T is not associated with susceptibility and clinical outcome of early-stage breast cancer WIEN KLIN WOCHENSCHR. 2012; 124(15-16):575-575.
(2012): A COMMON GENE VARIANT IN PLS3 PREDICTS COLON CANCER RECURRENCE IN WOMEN. ANN ONCOL. 2012; 23: 83-83.-14th World Congress on Gastrointestinal Cancer of the European-Society-for-Medical-Oncology (ESMO); JUN 27-30, 2012; Barcelona, SPAIN.
(2012): Genetic Variants in the TGF-beta 1 Gene and the Risk of Late Toxicity After Radiotherapy in Prostate Cancer Patients EUR J CANCER. 2012; 48: 87-87.-24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 06-09, 2012; Dublin, IRELAND.
(2012): Role of ERCC2 Gene polymorphisms in the development of radiation-induced Late effects in Prostate cancer patients. Strahlentherapie und Onkologie. 2012; 188(1):107-107.-18. Jahrestagung der Deutschen Gesellschaft für Radioonkologie; JUN 7-10, 2012; Wiesbaden, GERMANY.
(2012): Role of Polymorphisms in the ERCC2 Gene in the Development of Severe Side Effects After Radiotherapy of Prostate Cancer Patients. EUR J CANCER. EUROPEAN JOURNAL OF CANCER48: S271-S271. OXFORD: ELSEVIER SCI LTD; ( Presented at: 22nd Biennial Congress of the European-Association-for-Cancer-Research, Barcelona, SPAIN, JUL 07-10, 2012)
Abstracts (Konferenzband)
(2012): The role of VEGF Gene Polymorphism in the development of distant metastases in postmenopausal Breast cancer patients. Strahlentherapie und Onkologie. 2012. 2012; 188(1):65-65.-Jahrestagung der Deutschen Gesellschaft für Radioonkologie; JUN 7-10, 2012; Wiesbaden, GERMANY. (ISBN: 0179-7158 )
(2012): Correlations between variants in the ERCC2 gene and the risk of the development of radiation induced late toxicity in prostate cancer patients Onkologie - International Journal for Cancer Research and Treatment. 2012; 35(6):182-182.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Hämatologie und Onkologie; OKT 19-23, 2012; Stuttgart, GERMANY. (ISBN: 978-3-318-02304-6 )

2011 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2011): Novel immunofluorescence protocol for multimarker assessment of putative disseminating breast cancer stem cells. Appl Immunohistochem Mol Morphol. 2011; 19(1):33-40
(2011): Prolactin receptor is a negative prognostic factor in patients with squamous cell carcinoma of the head and neck. Br J Cancer. 2011; 104(10):1641-1648
(2011): Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Clin Cancer Res. 2011; 17(17):5783-5792
(2011): Single nucleotide polymorphisms of integrin alpha-2 and beta-3 genes are not associated with relapse-free and overall survival in colorectal cancer patients. Anticancer Res. 2011; 31(4):1373-1377
(2011): In vivo reflectance confocal microscopy: automated diagnostic image analysis of melanocytic skin tumours. J Eur Acad Dermatol Venereol. 2011; 25(5):554-558
(2011): Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients. Radiother Oncol. 2011; 98(3):387-393
(2011): Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlenther Onkol. 2011; 187(12):784-791
(2011): Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. Strahlenther Onkol. 2011; 187(2):100-107
(2011): Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial. J Clin Oncol. 2011; 29(19):2653-2659
(2011): External validation of the Leibovich prognosis score for nonmetastatic clear cell renal cell carcinoma at a single European center applying routine pathology. J Urol. 2011; 186(5):1773-1777
(2011): Infusion reactions to the chimeric EGFR inhibitor cetuximab--change to the fully human anti-EGFR monoclonal antibody panitumumab is safe. Ann Oncol. 2011; 22(2): 486-487.
(2011): Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems. Spine (Phila Pa 1976). 2011; 36(23): 1977-1986.
(2011): Computer-aided diagnosis of melanocytic skin tumors by use of confocal laser scanning microscopy images. Anal Quant Cytol Histol. 2011; 33(2):85-100
Kurzbericht/Letter
(2011): Pancreatic adenocarcinoma with multiple eosinophilic extracellular deposits consistent with noncalcified psammoma bodies. Virchows Arch. 2011; 459(6):623-625
(2011): COLD-HRM PCR versus Conventional HRM PCR to Detect the BRAF V600E Mutation A Real Improvement? J MOL DIAGN. 2011; 13(2): 243-243.
Übersichtsarbeiten
(2011): Disseminated and circulating tumor cells: Role in effective cancer management. Crit Rev Oncol Hematol. 2011; 77(1):1-11

2011 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2011): Preplanned subgroup analysis of ABCSG-12 suggests that benefits of adjuvant zoledronic acid (ZOL) are most pronounced in lowest estrogen environment BREAST. 2011; 20: S69-S69.St. Gallen .
(2011): 62-Month follow-up of ABCSG-12: Adjuvant endocrine therapy, alone or in combination with zoledronic acid, in premenopausal patients with endocrine-responsive early breast cancer BONE. 2011; 48(1):S17-S17.
(2011): Genetic differences in preoperative specimen of osteosarcoma and their impact on response to neoadjuvant chemotherapy ONKOLOGIE. 2011; 34: 251-252.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SCHWEIZ.
(2011): RELAPSE-FREE SURVIVAL IN COLORECTAL CANCER PATIENTS IS NOT ASSOCIATED WITH SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRIN RECEPTOR SUBUNITS ANN ONCOL. 2011; 22: v109-v109.-ESMO 13th World Congress on Gastrointestinal Cancer ; JUN 22-25, 2011; Barcelona, SPAIN.
(2011): A COMMON HEREDITARY SINGLE NUCLEOTIDE POLYMORPHISM IN THE IN THE GENE OF DEATH RECEPTOR 4 (TNFRSF10A) AND ITS IMPACT ON OVERALL SURVIVAL IN RECTAL CANCER PATIENTS ANN ONCOL. . 2011; 22: v129-v129.-ESMO 13th World Congress on Gastrointestinal Cancer; JUN 22-25, 2011; Barcelona, SPAIN.
(2011): Common single nucleotide polymorphisms in the genes of integrin alpha-2 and beta-3 subunits are not associated with overall survival in rectal cancer patients ONKOLOGIE. 2011; 34: 245-246.-Gemeinsame Jahrestagung 2011 der DGHO, ÖGHO, SGMO und SGH+SSH; SEP 30-OCT 4, 2011; Basel, SWITZERLAND.
(2011): Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donation. Transplant International, Supplement 2. 2011; 24: 276-276.-15th Conference of the European Society for Organ Transplantation; Sept 4-7, 2011; Glasgow, UK.
(2011): Benefit of chemotherapy in patients with ductal adenocarcinoma of the pancreas with vascular infiltration. ANN ONCOL. 2011; 22: v61-v61.-World Congress on Gastrointestinal Cancer (WCGIC); JUN 22-25, 2011; Barcelona, SPAIN.
(2011): Side effects - Prevention and Management. STRAHLENTHER ONKOL. 2011; 187(1):78-78.

2010 - Beiträge in Fachzeitschriften

Originalarbeiten (Zeitschrift)
(2010): Micrometastasis: detection methods and clinical importance. Cancer Biomark. 2010; 9(1-6):397-419
(2010): Growth suppression of human breast carcinoma stem cells by lipid peroxidation product 4-hydroxy-2-nonenal and hydroxyl radical-modified collagen. Acta Biochim Pol. 2010; 57(2):165-171
(2010): Association of interleukin-10 gene variation with breast cancer prognosis. Breast Cancer Res Treat. 2010; 119(3):701-705
(2010): Psychological distress among male patients and male spouses: what do oncologists need to know? Ann Oncol. 2010; 21(4): 877-883.
(2010): Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases. Mod Pathol. 2010; 23(7):961-971
(2010): Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer. J Cancer Res Clin Oncol. 2010; 136(12):1813-1819
(2010): Single nucleotide polymorphisms in the hypoxia-inducible factor-1 gene and colorectal cancer risk. Mol Carcinog. 2010; 49(9):805-809
(2010): Portable Filter-Based Microdevice for Detection and Characterization of Circulating Tumor Cells. Clin Cancer Res. 2010; 16(20):5011-5018
(2010): Behaviour of multipotent maxillary bone-derived cells on beta-tricalcium phosphate and highly porous bovine bone mineral. Clin Oral Implants Res. 2010; 21(7):699-708
(2010): Quantitative short-tandem repeat analysis of recipient-derived cells as an additional tool for diagnosing cardiac allograft rejection. Transplantation. 2010; 89(6): 749-755.
(2010): Rationale of a relaunch of gefitinib in Caucasian non-small cell lung cancer patients. Lung Cancer. 2010; 69(3): 265-271.
(2010): Follow-up of actinic keratoses after shave biopsy by in-vivo reflectance confocal microscopy--a pilot study. J Eur Acad Dermatol Venereol. 2010; 24(3):293-298
(2010): Rapid and reliable detection of LINE-1 hypomethylation using high-resolution melting analysis. Clin Biochem. 2010; 43(18):1443-1448
(2010): The role of activation-induced cell death in the higher onset of spontaneous apoptosis of NK cell subsets in patients with metastatic epithelial cancer. Cell Immunol. 2010; 261(2):99-104
(2010): Association of hypoxia-inducible factor 1-alpha gene polymorphisms and colorectal cancer prognosis. Anticancer Res. 2010; 30(6):2393-2397
(2010): Paraneoplastic limbic encephalitis in a patient with extragonadal choriocarcinoma--significance of onconeural antibodies. Onkologie. 2010; 33(8-9):452-454
(2010): Cloning and characterisation of GIRK1 variants resulting from alternative RNA editing of the KCNJ3 gene transcript in a human breast cancer cell line. J Cell Biochem. 2010; 110(3): 598-608.
Kurzbericht/Letter
(2010): PTCH promoter methylation at low level in sporadic basal cell carcinoma analysed by three different approaches. EXP DERMATOL. 2010; 19(10): 926-928.

2010 - Publizierte (zitierfähige) Beiträge für wissenschaftliche Veranstaltungen

Abstracts (Zeitschrift)
(2010): PSA velocity and PCA3 score as risk factors for prostate cancer in a repeat biopsy setting improves the predictive accuracy in a multivariate model. European Urology Supplements2010; 9(2):307--25th Anniversary European Association of Urology Congress; APR 16-20, 2010; Barcelona, SPAIN.
(2010): Systematic analysis of saturation biopsy with 20 peripheral cores and 4 cores from the transition zone based on 62 reduced biopsy schemes after at least one negative biopsy EUR UROL SUPPL. 2010; 9(6):654-654.-25th EAU Congress; APR 16-20, 2010; Barcelona/SPAIN.
(2010): ADJUVANT ENDOCRINE THERAPY, ALONE OR IN COMBINATION WITH ZOLEDRONIC ACID (ZOL), IN PREMENOPAUSAL PATIENTS (PTS) WITH ENDOCRINE-RESPONSIVE EARLY BREAST CANCER (EBC): SUBGROUP ANALYSES OF ABCSG-12 ANN ONCOL. 2010; 21: 79-79.
(2010): Prolactin Receptor Expression in Colorectal Cancer – Therapeutic Option for Affected Patients? Onkologie 2010; 33, Supplement 2: 63-63.-29. Deutscher Krebskongress; FEB 24-27, 2010; Berlin, Germany.
(2010): Prolactin Receptor Expression in Colorectal Cancer – Therapeutic Option for Affected Patients? Ann Oncol 2010; 21, Supplement 1: i 30-i 30.-European Multidisciplinary Colorectal Cancer Congress; Mar 28-30, 2010; Nice, France.
(2010): Hereditary variants of VEGF receptor genes and their impact on overall survival in rectal cancer. Onkologie2010; 33(S 6):174-174.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY.
(2010): COMMON VEGF RECEPTOR GENE POLYMORPHISMS AND THEIR INFLUENCE ON OVERALL SURVIVAL IN COLORECTAL CANCER PATIENTS Annals of Oncology2010; 21(S 6):35-35.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN.
(2010): ASSOCIATION OF COMMON SINGLE NUCLEOTIDE POLYMORPHISMS IN INTEGRINS WITH METASTASIS-FREE SURVIVAL IN RECTAL CANCER PATIENTS Annals of Oncology2010; 21(S 6):59-59.-12th World Congress on Gastrointestinal Cancer; June 30-July 3, 2010; Barcelona, SPAIN.
(2010): Association of a single nucleotide polymorphism in the gene of TNFRSF10A (TRAILR-1) with relapse-free survival in colorectal cancer. Onkologie2010; 33(S 6):173-173.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OCT 1-5, 2010; Berlin, GERMANY. (ISBN: 0378-584X )
(2010): Single nucleotide polymorphisms in the hypoxia-inducible factor 1 gene and colorectal cancer risk Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):225-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 )
(2010): The XRCC1 Arg280His polymorphism is associated with high-grade radiation-induced late toxicity in prostate cancer patients. EJC SUPPL. 2010; 8(7):167-167.-22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics; NOV 16-19, 2010; Berlin, GERMANY.
(2010): Independent prognostic factors for response: updated results of the ABCSG-24 study evaluating the addition of capecitabine to epirubicin-docetaxel neoadjuvant therapy for early breast cancer (EBC) EJC SUPPL. 2010; 8(3): 60-60.
(2010): ABCSG-24: EFFICACY OF ANTHRACYCLINE- AND TAXANE-BASED NEOADJUVANT THERAPY +/- CAPECITABINE (C) IN TRIPLE-NEGATIVE EARLY BREAST CANCER (TNBC) ANN ONCOL. 2010; 21: 79-79.
(2010): Association of Hypoxia Inducible Factor 1-alpha Gene Polymorphisms and Colorectal Cancer Prognosis. Onkologie-International Journal for Cancer Research and Treatment2010; 33(S6):226-226.-Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Onkologie; OKT 1-5, 2010; Berlin, GERMANY. (ISBN: 978-3-8055-9633-6 )
Abstracts (Konferenzband)
(2010): LAMA4 is Expressed by Clusters of Hypertrophic Chondrocytes in Osteoarthritic Cartilage and Regulated by Epigenetic Mechanisms. Abstracts of OARSI 2010; 268.2010; -OARSI 2010; SEP 23-26, 2010; Brussels, BELGIUM.